Investor’s Alert: Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), Cell Therapeutics Inc , GT Advanced Technologies Inc , Prospect Capital Corporation

Submitted By on September 17, 2013 - 11:36 AM

Middletown, DE — (TechSonian) — 09/17/2013 –VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), Cell Therapeutics Inc (NASDAQ:CTIC), GT Advanced Technologies Inc (NASDAQ:GTAT), Prospect Capital Corporation (NASDAQ:PSEC).

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), ended with a volume of 2.58 million shares versus the average volume of the stock 4.45 million shares. The stock decreased -0.81% and ended at $8.55. The market capitalization of the stock remained 818.79 million. The beta of the stock was 1.09.

Has ASTX Found The Bottom and Ready To Move Up? Find Out Here

Astex Pharmaceuticals, Inc. engages in the discovery and development of small molecule therapeutics with a focus on oncology and hematology using its fragment-based drug discovery platform, Pyramid.

Cell Therapeutics Inc (NASDAQ:CTIC), traded 2.55 million shares in the last business day while the average volume of the stock remained 1.01 million shares. The 52 week range of the stock remained $0.97 – $3.14. The stock showed a negative movement of -5.34% to end at $1.24. The market capitalization of the stock remained 142.32 billion.

Will CTIC Get Buyers Even After The Recent Rally? Find Out Here

Cell Therapeutics, Inc. engages in the acquisition, development, and commercialization of treatments for cancer. The company primary focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in Phase III clinical trials for the treatment of multiply relapsed or refractory aggressive non-Hodgkin lymphoma.

GT Advanced Technologies Inc (NASDAQ:GTAT), its volume was 2.52 million shares as compared to the average volume of 4.29 shares. The stock boosted2.44% in its last trading session and reached a price of $6.73. The stock, on average, trades 4.29 shares each day.

Will GTAT Continue To Move Higher? Find Out Here

GT Advanced Technologies Inc. provides crystal growth equipment and solutions for the solar, light emitting diode (LED), and electronics industries worldwide.

Prospect Capital Corporation (NASDAQ:PSEC) showed a volume of 2.48 million shares by the end of last trade whereas the average volume of the stock remained 2.74 million shares. The 52 week range of the stock remained $9.80 – $12.25 and the day range was $11.50 – $11.56. The stock opened the session at $11.55 but then moved to $11.53. At that price, the stock showed a positive performance of 0.52%.

Will PSEC Continue To Move Higher? Find Out Here

Prospect Capital Corporation is a business development company. It specializes in middle market, mature, mezzanine finance, later stage, emerging growth, buyouts, recapitalizations, turnaround, growth capital, development, cash flow term loans, and bridge transactions.

About VipStockReports.com:

We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the ‘Next Hot Penny Stock’ with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!

Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.

Disclaimer:

VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.

VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.

Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/